期刊文献+

实时荧光定量PCR检测急性白血病的肝细胞生长因子mRNA的表达及其意义 被引量:1

The clinical significance of real-tlme fluorescence PCR quantification of hepatocyte growth factor mRNA expression in acute leukemia
原文传递
导出
摘要 目的定量检测急性白血病(AL)骨髓单个核细胞(MNCs)的肝细胞生长因子(HGF)mRNA的表达,并探讨其临床意义。方法制备67例初治AL患者的骨髓MNCs,提取定量MNCs的总RNA,并制备cDNA。应用实时荧光定量-PCR(FQ-PCR)检测HGF mRNA在AL的表达。结果HGF mRNA在AL组的表达显著高于对照组(6.936±1.613,0.407±0.170,P〈0.001),而急性髓系白血病(AML)和急性淋巴细胞白血病(ALL)的表达差异无统计学意义(7.127±1.911,6.635±0.934,P〉0.05)。在AL中,M5呈显著强表达(9.998±1.454),高于M2、M3、M4、L1、L2和L3表达(P〈0.001);而后者间表达差异无统计学意义(P〉0.05)。HGF mRNA在性别、年龄间的表达差异也无统计学意义(P〉0.05)。缓解组HGF mRNA的表达明显低于未缓解组(6.393±1.165,8.041±1.848,P〈0.005)。结论HGF mRNA在AL组与对照组、AL亚型间的表达存在差异,但在AML与ALL、AL患者的性别、年龄间的表达无差异。且低表达者疗效较好,提示HGF mRNA可能是AL诊治的又一理想指标。 Objective To detect quantitatively hepatocyte growth factor (HGF) mRNA expressions of bone marrow mononuclear cells (MNCs) in acute leukemia (AL) and investigate its clinical significance. Methods Total mRNA of quantitated bone marrow MNCs isolated from 67 de novo AL cases was extrated and then cDNA was synthesized. Expression of HGF mRNA was quantified absolutely using real-time fluorescence quantification PCR (FQ-PCR). Results Expressions of HGF mRNA in a group of AL were higher significantly than these in a control group (6. 936 ± 1. 613, 0. 407 ± 0. 170, P 〈 0. 001 ), but there was similarity between a group of acute myeloid leukemia (AML) and group of acute lymphoblastic leukemia (ALL) (7. 127 ± 1. 911, 6. 635 ± 0. 934, P 〉 0. 05 ). In AL subtypes, the expression of M5 (9. 998 ± 1. 454) was higher than that of M2, M3, M4, L1, L2 and L3 (P 〈 0. 001 ) , but there ware no differences among the latters (P 〉 0.05 ). Meanwhile, there was no statistical significance on the expressions of HGF mRNA between different age and sex (P 〉0. 05). In addition, expressions of HGF mRNA in the remission group were lower than these in the non-remission group ( 6. 393 ± 1. 165, 8.041 ± 1. 848, P 〈 0. 005 ). Conclusions There are statistical significances of the expressions of bone marrow MNCs HGF mRNA among the AL group and control group. As to AL subtypes, there are no statistically significant differences between AML and ALL as well as between different age and sex. Besides, lower HGF mRNA level is correlated with better curative effect. It is suggested that HGF mRNA is a suitable index for AL diagnosis and treatment.
出处 《中华内科杂志》 CAS CSCD 北大核心 2008年第5期401-404,共4页 Chinese Journal of Internal Medicine
基金 浙江省自然科学基金重大资助项目(ZB0202) 浙江省宁波市医学科技基金(2003079) 浙江省医药卫生科学研究基金(2007A175)
关键词 白血病 肝细胞生长因子 聚合酶链反应 Leukemia Hepatocyte growth factor Polymerase chain reaction
  • 相关文献

参考文献13

  • 1Derksen PW, de Gorter DJ, Meijer HP, et al. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. Leukemia, 2003, 17:764-774.
  • 2Forte G, Minieri M, Cossa P, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells, 2006, 24:23-33.
  • 3Gwang K J, Kyun SS, Hwan KD, et al. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma,2005,46:885-891.
  • 4Tjin EP, Groen RW, Vogelzang I, et al. Functional analysis of HGF/MET-signaling and aberrant HGF-activator expression in diffuse large B cell lymphoma. Blood, 2006, 107:760-768.
  • 5Pons E, Uphoff C, Drexler HG. Expression of hepatocyte growth factor and its receptor C-met in human leukemia-lymphoma cell lines. Leuk Res, 1998, 22:797-804.
  • 6Verstovsek S, Kantarjian H, Estey E, et al. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. Leukemia, 2001, 15:1165-1170.
  • 7Aref S, Mabed M, Sakrana M, et al. Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics. Hematology, 2002, 7:273-279.
  • 8Jiang WG, Davies G, Martin TA, et al. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo. Int J Mol Med, 2005, 16:723-728.
  • 9Nishizaki K, Dohi Y, Kiji T, et al. Evaluation of rat arterial allograft viability by measuring cytokine mRNA using real-time quantitative PCR. Transplant Proc, 2003, 35:96-98.
  • 10SambrookJ, Russell DW. Molecular cloning; A laboratory manual. 3rd ed. New York: Cold Spring Harbor laboratory press, 2001,8:86-112.

二级参考文献7

  • 1Nakamura K, Nishizawa T, Higiya M, et al. Molecular cloning and expression of human hepatocyte growth factor[J]. Nature, 1989,342:440- 443.
  • 2Grenier A, Chollet-Martin S, Crestani B, et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonulear neutrophils[ J]. Blood,2002, Apr15; 99(8) :2997 - 3004.
  • 3Harrison P, Gove C, Bomfont A. Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure[J]. Dig Dis Sci, 2000,45(10) :1913 - 1920.
  • 4Alexandrakis MG, Passam FH, Sfiridaki A, et al. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markets of disease activity[J]. Am J Hexaatol,2003, Apr;72(4) :229 - 233.
  • 5Sambrook J, Russell D.W. Molecular Cloning: A Laboratory Manual[M].3rd ed. New York:Cold Spring Harbor laboratory press,2001,1.59 - 5.23.
  • 6Gerard CJ, Olsson K, Ramanathan R, et al. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmaid-DNA complementarity determining region Ⅲ standards [ J]. Cancex Research, 1998, 58 ( 17): 3957 -3964..
  • 7高劲松,马刚,仝明,陈佩毅,王传华,何蕴韶.荧光定量RT-PCR检测mdr-1基因表达[J].癌症,2000,19(3):200-203. 被引量:13

同被引文献12

  • 1NAKAMURA K,NISHIZAWA T,HIGIYA M,et al.Molecular cloning and expression of human hepatocyte growth factor[J].Nature,1989,342(6248):440-443.
  • 2FORTE G,MINIERI M,COSSA P,et al.Hepatocyte growth factor effects on mesenchymal stem cells:proliferation,migration,and differentiation[J].Stem Cells,2006,24(1):23-33.
  • 3TJIN E P,GROEN R W,VOGELZANG I,et al.Functional analysis of HGF/MET-signaling and aberrant HGF-activator expression in diffuse large B cell lymphoma[J].Blood,2006,107(2):760-768.
  • 4SON G,HIRANO T,SEKI E,et al.Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice[J].J Hepatol,2006,45(5):688-695.
  • 5JIANG W G,DAVIES G,MARTIN T A,et al.The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo[J].Int J Mol Med,2005,16(4):723-728.
  • 6TOYAMA T,IDO A,SASAK H,et al.Possible involvement of neutrophils in a serum level increase of hepatocyte growth factor in non-Hodgkin's lymphoma[J].Oncol Rep,2005,13(3):439-444.
  • 7KANEHIRA M,XIN H,HOSHINO K,et al.Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells[J].Cancer Gene Ther,2007,14(11):894-903.
  • 8OKASORA T,JO JI,TABATA Y.Augmented anti-tumor therapy through natural targetability of macrophages genetically engineered by NK4 plasmid DNA[J].Gene Ther,2008,15(7):524-530.
  • 9DU W,HATTORI Y,YAMADA T,et al.NK4,an antagonist of hepatocyte growth factor (HGF),inhibits growth of multiple myeloma cells:molecular targeting of angiogenic growth factor[J].Blood,2007,109(7):3042-3049.
  • 10ZOU H Y,LI Q,LEE J H,et al.An orally available small-molecule inhibitor of c-Met,PF-2341066,exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms[J].Cancer Res,2007,67(9):4408-4417.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部